发明名称 INHIBITORS OF MUTANT FORM OF KINASE KIT
摘要 FIELD: medicine. ^ SUBSTANCE: invention can be used for treatment dependent from kinase KIT diseases which are characterised by mutant forms of kinase KIT. A mutant of kinase KIT is identified and a bond A is entered, inhibiting the mutant form of kinase KIT. ^ EFFECT: invention use allows treating diseases dependent from kinase KIT at the expense of suppression of the alarm cascade of this enzyme leading to superfluous proliferation of cells. ^ 13 cl, 1 dwg, 1 ex, 1 tbl
申请公布号 RU2362562(C2) 申请公布日期 2009.07.27
申请号 RU20060121447 申请日期 2004.11.17
申请人 NOVARTIS AG 发明人 BUKHDUNGER EHLIZABET;FABBRO DORIANO
分类号 A61K31/502;A61K31/506;A61K31/553;A61P35/00 主分类号 A61K31/502
代理机构 代理人
主权项
地址